ALVO
Alvotech
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IS
$5.03
+0.60%Forward multiples
Based on analyst estimates
- P/E forward
- 21.44x
- P/E 2026E
- —
- P/E 2027E
- 22.34x
- P/E 2028E
- 11.45x
- P/S forward
- 2.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -9.37x
- Price / sales
- 3.65x
- Price / cash flow
- -9.03x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 6.31x
- EV / EBITDA
- 475.10x
- EV / EBIT
- 65.59x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026